Search

everythinglearnresearchcommunity

for

Search:↓

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

TPA is about 50 times more effective at promoting tumors than MZ.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

The EFSUMB created basic guidelines for using ultrasound in skin-related medical practice.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Liver transplantation is a viable option for children with propionic acidemia, improving quality of life and diet, but does not remove all risks and long-term brain outcomes are uncertain.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Cells in hair follicles help create fat cells in the skin by releasing a protein called Sonic Hedgehog.

Aging mice have slower hair regeneration due to changes in signal balance, but the environment, not stem cell loss, controls this, suggesting treatments could focus on environmental factors.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Mutations in the DSG4 gene can cause a rare hair disorder similar to monilethrix.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Prolactin affects when mice shed and grow hair.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

TRH stimulates human hair growth and extends the hair growth phase.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.